HC Wainwright & Co. Initiates Coverage On Evommune with Buy Rating, Announces Price Target of $35

Benzinga · 5d ago
HC Wainwright & Co. analyst Mitchell S. Kapoor initiates coverage on Evommune (NYSE:EVMN) with a Buy rating and announces Price Target of $35.